Perbandingan Pemberian Obat Seftriakson dan Levofloksasin Terhadap Kadar Kreatinin Serum Pasien Pneumonia Rawat Inap di RS Citra Sari Husada Karawang Tahun 2017 - 2018

Bimayudo Aprialdi, Erna Harfiani, Hany Yusmaini

Abstract


Pneumonia is a disease that occurs throughout the world with the most common cases in young children and pre-elderly people. Pneumonia can be caused by Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa. Therefore ceftriaxone and levofloxacin antibiotic therapy may be given, with a side effects of nephrotoxicity. Nephrotoxicity can be seen from the increase in creatinine levels prior and following the administration of ceftriaxone and levofloxacin. This study aims to determine the comparison of ceftriaxone and levofloxacin drugs to serum creatinine levels in hospitalized patients with pneumonia at Citra Sari Husada Hospital, Karawang, 2017-2018. This research is analytic observational study with cross-sectional design. The research samples taken from medical data records of hospitalized pneumonia patients in the 45-59 years group age with purposive sampling method at Citra Sari Husada Hospital, Karawang. The study sample size is 68 with the shortest 5 days and the longest 13 days in hospital. Mann-Whitney U test results found no significant differences between ceftriaxone and levofloxacin administration compared to serum creatinine levels of pneumonia patient's. The conclusion of this study suggest that there are no significant differences between ceftriaxone and levofloxacin drugs administration against serum creatinine levels of hospitalized pneumonia patients at Citra Sari Husada Hospital, Karawang in 2017-2018.

Full Text:

PDF

References


Lantu MG, Loho E, Ali RH. Gambaran Foto Toraks Pada Efusi Pleura Di Bagian/Smf Radiologi Fk Unsrat Rsup Prof. Dr. R.D. Kandou Manado Periode November 2014 – Oktober 2015. e-CliniC; 4. Epub ahead of print 2016. DOI: 10.35790/ecl.4.1.2016.10966.

Riskesdas. Hasil Utama Riset Kesehatan Dasar. Kementrian Kesehat Republik Indones 2018; 1–100.

Kementrian Kesehatan Republik Indonesia. Pedoman Pelayanan Kefarmasian Untuk Terapi Antibiotika Kementrian Kesehatan Republik Indonesia.

Wulansari N, Mahawati E, Hartini E. Kajian Penggunaan Antibiotik Pada Pasien Pneumonia di Bangsal Paru RSUP Dr. M. Djamil Padang Dengan Metoda Gyssens Bulan Januari-Desember 2017.

Sudoyo AW, Setiyohadi B, Alwi I, Simadibrata M SS. Buku Ajar Ilmu. Penyakit Dalam Jilid II edisi V. Jakarta: Interna Publishing. 2009.

Yunarto N. Revitalisasi Penggunaan Obat Generik. Farmasains J Farm dan Ilmu Kesehat; 1. Epub ahead of print 2012. DOI: 10.22219/far.v1i2.1170.

Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin Infect Dis 2007; 44: S27–S72.

Bulan G, Desember J, Yelly P, et al. Pneumonia di Bangsal Paru RSUP DR . M . Djamil Padang Dengan Metoda Radika Vionita. 2018; 1–3.

Deasy. Pada Pasien Pneumonia Dewasa Di Instalasi Rawat Inap Rsud Dr . Moewardi Surakarta Rawat Inap Rsud Dr . Moewardi Surakarta, https://eprints.uns.ac.id/28632/1/M3513016_pendahuluan.pdf (2016).

Setiabudi R. Pengantar Antimikroba, dalam Farmakologi dan Terapi Edisi 5. Jakarta: Balai Penerbit FKUI.

Huo X, Meng Q, Wang C, et al. Cilastatin protects against imipenem-induced nephrotoxicity via inhibition of renal organic anion transporters (OATs). Acta Pharm Sin B. Epub ahead of print 2019. DOI: 10.1016/j.apsb.2019.02.005.

Purnasari C, Manggau MA, Farmasi F, et al. Studi Pengaruh Dosis Dan Lama Penggunaan. 2018; 22: 76–80.

Alfonso. Gambaran Kadar Kreatinin Serum Pada Pasian Penyakit Ginjal Kronik Stadium 5 Non Dialisis.

Safitri S. Evaluasi Penggunaan Antibiotik Pada Pasien Pneumonia Di Instalasi Rawat Inap Rs “X” Klaten Tahun 2015. CoreAcUk, https://core.ac.uk/download/pdf/148617687.pdf (2015).

Nugroho. Komunikasi dalam Keperawatan Gerontik.

Kato H, Hamada Y, Hagihara M, et al. Retrospective study of teicoplanin loading regimen that rapidly achieves target 15-30 μg/mL serum trough concentration. J Infect Chemother 2016; 22: 308–313.

Decker BS, Molitoris BA. Aminoglycoside-Induced Nephrotoxicity. Third Edit. Elsevier. Epub ahead of print 2017. DOI: 10.1016/B978-0-12-801238-3.95646-0.

Farida Y, Trisna A, Nur D. Study of Antibiotic Use on Pneumonia Patient in Surakarta Referral Hospital. JPSCR J Pharm Sci Clin Res 2017; 2: 44.

Kwon KH, Oh JY, Yoon YS, et al. Colistin treatment in carbapenem-resistant Acinetobacter baumannii pneumonia patients: Incidence of nephrotoxicity and outcomes. Int J Antimicrob Agents 2015; 45: 605–609.

Cano EL, Haque NZ, Welch VL, et al. Incidence of Nephrotoxicity and Association With Vancomycin Use in Intensive Care Unit Patients With Pneumonia: Retrospective Analysis of the IMPACT-HAP Database. Clin Ther 2012; 34: 149–157.

Shargel, L, Andrew, BC & Sussanna W. Apllied Biopharmaceutics and Biopharmakokinetics 5th Ed.

Pratiwi RR& AW. Pengetahuan mengenai antibiotika di kalangan mahasiswa ilmu-ilmu kesehatan Universitas Gadjah Mada Yogyakarta.

BPOM RI. Cravit Kaptab Salut selaput 750 mg_Levofloksasin_DKL1711645109A1_2018 (1).pdf.

Sharma PC; Jain A; Fluoroquinolones antibacterials: a review on chemistry, microbiology and therapeutic prospects.


Refbacks

  • There are currently no refbacks.


Sekretariat SENSORIK :

Ruang Jurnal Lantai 2, Gedung Cipto Mangunkusumo, Fakultas Kedokteran, UPN Veteran Jakarta, Indonesia.

Copyright © some right reserved Seminar Nasional Riset Kedokteran (SENSORIK).

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 International License.